Company news

Brii Biosciences Limited news in 2024

Brii Biosciences Limited's news releases, calls and decks from 2024, newest first.

View company

Brii Bio Presents New Data from Its Ongoing Phase 2 Chronic Hepatitis B Trials at EASL™ Congress 2024

June 7, 2024

Brii Biosciences Announces Two Breakthrough Therapy Designations for BRII-877 and BRII-835 Building on Extensive Clinical Evidence from Multiple Phase 2 Studies

May 13, 2024

Brii Biosciences Announces Agreements To Acquire VBI Vaccines' IP Rights In BRII-179

March 5, 2024

Brii Biosciences Announces Agreement to Acquire VBI's IP Rights in BRII-179 (VBI-2601) and Plans to Initiate Technology Transfer to Expand Clinical and Commercial Supplies

February 13, 2024

Brii Biosciences Appoints Dr. Brian Alvin Johns as Chief Scientific Officer

January 3, 2024

Decks in 2024